Medicare Enrolled
Dr. Urmeel Patel, M.D.
Hematology & Oncology · Shenandoah, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Patel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Patel?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Patel
Dr. Urmeel Patel is a hematology & oncology specialist in Shenandoah, TX, with 14 years of NPI registration. Based on federal Medicare data, Dr. Patel performed 127,457 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Patel received a total of $54,466 from 107 pharmaceutical and/or device companies across 1257 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Patel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years of NPI registration
▲ Top 4% volume in TX
$54,466 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗127,457
Medicare services
Top 4% in TX for hematology & oncology
Not available
Unique patients (not deduplicated)
$4
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
81,000 | $1 | $3 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
11,850 | $0 | $1 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
10,400 | $0 | $0 |
| Denosumab injection (Prolia/Xgeva) | 10,380 | $18 | $54 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,878 | $0 | $0 |
| MRI contrast dye injection (gadoterate) Administration of gadoterate meglumine, a contrast agent, in a 0.1 ml dose. |
2,800 | $0 | $0 |
| Anti-nausea injection (ondansetron/Zofran) | 1,904 | $0 | $0 |
| Flow cytometry, additional marker An additional marker is tested during a flow cytometry procedure to analyze DNA or cells. This step adds specific data points to the initial analysis. |
1,579 | $19 | $62 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,101 | $1 | $6 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
733 | $23 | $82 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
728 | $92 | $346 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
341 | $100 | $374 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
315 | $11 | $38 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
216 | $63 | $244 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
162 | $50 | $179 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
150 | $50 | $183 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
121 | $22 | $80 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
76 | $131 | $480 |
| Flow cytometry DNA or cell analysis, first marker A laboratory test that uses a laser to analyze cells or DNA by detecting a specific marker on the cell surface or within the cell. |
69 | $55 | $189 |
| CT scan of chest with and without contrast A computed tomography scan of the chest performed using both intravenous contrast dye and without it to provide detailed images of internal structures. |
68 | $58 | $519 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
63 | $193 | $906 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
56 | $89 | $287 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
55 | $19 | $74 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
51 | $1 | $3 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
50 | $1,149 | $5,253 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 50 | $109 | $295 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
45 | $123 | $445 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
29 | $10 | $36 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
27 | $2 | $7 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
25 | $43 | $331 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
24 | $64 | $416 |
| New patient office visit, complex (60-74 min) | 20 | $170 | $597 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
19 | $74 | $466 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
16 | $165 | $807 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
16 | $134 | $501 |
| Whole body bone and joint nuclear medicine scan A nuclear medicine imaging test that uses a radioactive tracer to create pictures of the entire skeleton and joints. This scan helps evaluate bone health and detect abnormalities throughout the body. |
15 | $140 | $748 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
13 | $18 | $63 |
| Bone marrow biopsy and aspiration A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions. |
12 | $131 | $480 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
64.7% high complexity
33.0% medium
2.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$54,466
Total received (2018-2024)
Avg $7,781/year across 7 years
Top 11% in TX for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
107
Companies
1,257
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$20,409
2023
$18,871
2022
$4,947
2021
$3,617
2020
$1,636
2019
$3,990
2018
$997
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$5,754
Pharmacosmos Therapeutics Inc.
$3,048
Regeneron Pharmaceuticals, Inc.
$2,970
Karyopharm Therapeutics Inc.
$2,399
US Oncology Corporate, Inc.
$1,202
ABBVIE INC.
$465
Novartis Pharmaceuticals Corporation
$343
Celgene Corporation
$281
GENZYME CORPORATION
$278
SOBI, INC
$237
Eisai Inc.
$230
Astellas Pharma US Inc
$213
PFIZER INC.
$184
E.R. Squibb & Sons, L.L.C.
$174
Janssen Biotech, Inc.
$166
Merck Sharp & Dohme LLC
$157
Daiichi Sankyo Inc.
$146
GlaxoSmithKline, LLC.
$144
Lilly USA, LLC
$126
Gilead Sciences, Inc.
$108
Incyte Corporation
$104
Rigel Pharmaceuticals, Inc.
$103
TerSera Therapeutics LLC
$91
Blueprint Medicines Corporation
$91
Takeda Pharmaceuticals U.S.A., Inc.
$88
Dendreon Pharmaceuticals LLC
$87
Stemline Therapeutics Inc.
$87
JAZZ PHARMACEUTICALS INC.
$86
Boston Scientific Corporation
$78
Emmaus Medical, Inc.
$68
SpringWorks Therapeutics, Inc.
$65
BeiGene USA, Inc.
$59
Adaptive Biotechnologies Corporation
$59
Kite Pharma, Inc.
$56
Sirtex Medical Inc
$55
Alexion Pharmaceuticals, Inc.
$53
Janssen Pharmaceuticals, Inc
$52
TAIHO ONCOLOGY, INC.
$52
PharmaEssentia USA Corporation
$43
Tempus AI, Inc
$41
Regeneron Healthcare Solutions, Inc.
$40
Fennec Pharmaceuticals, Inc.
$36
Aveo Pharmaceuticals, Inc.
$36
Mirati Therapeutics, Inc.
$34
Spectrum Pharmaceuticals Inc.
$32
Ipsen Biopharmaceuticals, Inc
$31
Bayer Healthcare Pharmaceuticals Inc.
$31
Azurity Pharmaceuticals, Inc.
$24
Deciphera Pharmaceuticals Inc.
$19
Genentech USA, Inc.
$18
Pharming Healthcare, Inc.
$18
PUMA BIOTECHNOLOGY, INC.
$16
Secura Bio, Inc.
$15
RECORDATI_RARE_DISEASES_INC.
$13
Top 3 companies account for 57.7% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$10,538
Bayer Healthcare Pharmaceuticals Inc.
$7,013
Regeneron Pharmaceuticals, Inc.
$3,112
Pharmacosmos Therapeutics Inc.
$3,097
Janssen Biotech, Inc.
$2,774
Genentech USA, Inc.
$2,747
Karyopharm Therapeutics Inc.
$2,566
Novartis Pharmaceuticals Corporation
$1,588
Amgen Inc.
$1,444
US Oncology Corporate, Inc.
$1,202
GENZYME CORPORATION
$978
Celgene Corporation
$959
Daiichi Sankyo Inc.
$926
GlaxoSmithKline, LLC.
$919
E.R. Squibb & Sons, L.L.C.
$915
Astellas Pharma US Inc
$850
PFIZER INC.
$829
Lilly USA, LLC
$657
ABBVIE INC.
$623
Seagen Inc.
$559
Takeda Pharmaceuticals U.S.A., Inc.
$480
Incyte Corporation
$450
Eisai Inc.
$437
Rigel Pharmaceuticals, Inc.
$378
Gilead Sciences, Inc.
$378
SOBI, INC
$362
Alexion Pharmaceuticals, Inc.
$346
Bayer HealthCare Pharmaceuticals Inc.
$323
Dendreon Pharmaceuticals LLC
$308
Merck Sharp & Dohme LLC
$298
Sirtex Medical Inc
$280
Regeneron Healthcare Solutions, Inc.
$271
EISAI INC.
$239
Stemline Therapeutics Inc.
$237
Ipsen Biopharmaceuticals, Inc
$225
Merck Sharp & Dohme Corporation
$217
Myriad Genetic Laboratories, Inc.
$208
AVEO Pharmaceuticals, Inc.
$205
Janssen Pharmaceuticals, Inc
$203
Foundation Medicine, Inc.
$201
BeiGene USA, Inc.
$181
Pharmacyclics LLC, An AbbVie Company
$180
PUMA BIOTECHNOLOGY, INC.
$168
Blueprint Medicines Corporation
$163
Emmaus Medical, Inc.
$163
Mirati Therapeutics, Inc.
$143
TerSera Therapeutics LLC
$142
Adaptive Biotechnologies Corporation
$129
JAZZ PHARMACEUTICALS INC.
$125
Deciphera Pharmaceuticals Inc.
$117
ARRAY BIOPHARMA INC
$116
TAIHO ONCOLOGY, INC.
$116
Dova Pharmaceuticals
$110
Boston Scientific Corporation
$109
Seattle Genetics, Inc.
$108
Puma Biotechnology, Inc.
$97
PharmaEssentia USA Corporation
$94
Verastem, Inc.
$94
Taiho Oncology, Inc.
$91
Boehringer Ingelheim Pharmaceuticals, Inc.
$91
MorphoSys, US Inc.
$91
Kite Pharma, Inc.
$86
SpringWorks Therapeutics, Inc.
$65
Blue Earth Diagnostics Limited
$64
CTI BioPharma Corp.
$64
Nestle HealthCare Nutrition Inc.
$61
Exelixis Inc.
$59
G1 Therapeutics, Inc.
$57
AbbVie Inc.
$56
Aveo Pharmaceuticals, Inc.
$51
Myovant Sciences Inc.
$50
Spectrum Pharmaceuticals Inc.
$47
Kyowa Kirin, Inc.
$43
Tempus AI, Inc
$41
Teva Pharmaceuticals USA, Inc.
$38
Alnylam Pharmaceuticals Inc.
$36
Servier Pharmaceuticals LLC
$36
Fennec Pharmaceuticals, Inc.
$36
Sobi, Inc
$34
Acrotech Biopharma LLC
$34
Apellis Pharmaceuticals, Inc.
$33
Pharming Healthcare, Inc.
$32
AMAG Pharmaceuticals, Inc.
$32
Agios Pharmaceuticals, Inc.
$27
Secura Bio, Inc.
$26
Pharmacyclics LLC, an AbbVie Company
$25
TOLMAR Pharmaceuticals, Inc.
$25
Shield Therapeutics Inc
$24
Biocompatibles, Inc.
$24
Azurity Pharmaceuticals, Inc.
$24
Clovis Oncology, Inc.
$23
Jazz Pharmaceuticals Inc.
$22
EMD Serono, Inc.
$21
Aurobindo Pharma USA, Inc.
$21
Verity Pharmaceuticals Inc.
$21
TESARO, Inc.
$16
Sun Pharmaceutical Industries Inc.
$15
Lexicon Pharmaceuticals, Inc.
$14
Epizyme, Inc.,
$14
Tactile Systems Technology Inc
$14
Immunomedics, Inc.
$14
Coherus Biosciences Inc.
$14
RECORDATI_RARE_DISEASES_INC.
$13
EUSA Pharma (US) LLC
$13
ADC Therapeutics America, Inc.
$13
Heron Therapeutics, Inc.
$12
Genentech, Inc.
$6
Top 3 companies account for 37.9% of all-time payments
Associated products mentioned in payments ›
ABECMA · ACCRUFER · ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · AVYCAZ · AYVAKIT · Abraxane · Alecensa · Axumin · BELEODAQ · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CINVANTI · COPIKTRA · COSELA · CYRAMZA · Cabometyx · Columvi · Copiktra · DARZALEX · DOPTELET · Doptelet · ELIGARD · ELIQUIS · ELITEK · ELREXFIO · EMEND · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · EVENITY · EXKIVITY · Empaveli · Endari · Enhertu · FERAHEME · FOLOTYN · FOTIVDA · FOUNDATIONONE · Fabhalta · Farydak · Flexitouch Plus · Folotyn · GAZYVA · GILOTRIF · GIVLAARI · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · Imbruvica · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LINZESS · LONSURF · LORBRENA · LUMAKRAS · LUPRON DEPOT · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYRISK · Monoferric · NERLYNX · NINLARO · Neulasta · Nexavar · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · OXLUMO · Onivyde · Orserdu · PADCEV · PIQRAY · POLIVY · POTELIGEO · PRECISETUMOR · PROMACTA · PROVENGE · Padcev · Pedmark · Perjeta · Phesgo · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · RETEVMO · ROLVEDON · RUCONEST · RYBREVANT · Rezlidhia · Rituxan · Rubraca · SANDOSTATIN · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SYLVANT · SYNAGIS · Stivarga · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEPMETKO · THERASPHERE - BIO · TIBSOVO · TUKYSA · TUMOR LYSIS SYNDROME - DISEASE · Tavalisse · Tazverik · TheraSphere Y90 Glass Microspheres 10 GBq · Trelstar · Trodelvy · Truxima · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VIVIMUSTA · VONJO · VOTRIENT · VYXEOS · Vectibix · Venclexta · Vonjo · Vyloy · XALKORI · XARELTO · XGEVA · XPOVIO · XT CDX · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZENPEP · ZEPZELCA · ZOLADEX · Zoladex · clonoSEQ · myRisk
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
27
County median income
$97,266
Nearest hospital to ZIP centroid (approximate)
ST LUKE'S THE WOODLANDS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Patel is a mixed practice specialist, with above-average Medicare volume (top 4% in TX).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Patel experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Patel performed 81,000 iron infusion (injectafer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Patel receive payments from pharmaceutical companies?
Yes. Dr. Patel received a total of $54,466 from 107 companies across 1,257 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Patel's costs compare to other hematology & oncology specialists in Shenandoah?
Dr. Patel's average Medicare payment per service is $4. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Patel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Shenandoah
Browse hematology & oncology specialists in Shenandoah ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in TX
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in TX
Which TX hematology & oncology specialists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Bayer Healthcare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer Healthcare Pharmaceuticals Inc.
By company
Regeneron Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Regeneron Pharmaceuticals, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology